CH Biotech R&D Co (TPE:6534) Interest Expense: NT$-17 Mil (TTM As of Dec. 2025)


TPE:6534 CH Biotech R&D Co Ltd TPE:6534
84 GF Score
Price NT$93.00
GF Value NT$100.68
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is CH Biotech R&D Co Interest Expense?

CH Biotech R&D Co TPE:6534 84 Interest Expense is NT$-17 Mil as of Dec. 2025. GuruFocus rates TPE:6534 with a GF Score™ of 84/100 and a GF Value™ of NT$100.68 (Fairly Valued). The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CH Biotech R&D Co's interest expense for the three months ended in Dec. 2025 was NT$ -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-17 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CH Biotech R&D Co's Operating Income for the three months ended in Dec. 2025 was NT$ 42 Mil. CH Biotech R&D Co's Interest Expense for the three months ended in Dec. 2025 was NT$ -4 Mil. CH Biotech R&D Co's Interest Coverage for the quarter that ended in Dec. 2025 was 11.74. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CH Biotech R&D Co  (TPE:6534) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CH Biotech R&D Co's Interest Expense for the three months ended in Dec. 2025 was NT$-4 Mil. Its Operating Income for the three months ended in Dec. 2025 was NT$42 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2025 was NT$166 Mil.

CH Biotech R&D Co's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*41.999/-3.576
=11.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

CH Biotech R&D Co Interest Expense Historical Data

* Premium members only.

The historical data trend for CH Biotech R&D Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CH Biotech R&D Co Interest Expense Chart

CH Biotech R&D Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.90 -16.81 -16.81 -15.00 -16.96

CH Biotech R&D Co Quarterly Data
Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.82 -3.89 -4.60 -4.90 -3.58
TPE:6534
84GF Score
CH Biotech R&D Co Ltd TPE:6534
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CH Biotech R&D Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of NT$-17 Mil mean?
CH Biotech R&D Co (TPE:6534) has a Interest Expense of NT$-17 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on CH Biotech R&D Co and its competitors.
Is CH Biotech R&D Co's Interest Expense too high?
CH Biotech R&D Co's current Interest Expense is NT$-17 Mil. Overall, CH Biotech R&D Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's Interest Expense compare to CTVA and CF?
CH Biotech R&D Co's Interest Expense of NT$-17 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for an Agriculture company?
A good Interest Expense depends on the Agriculture industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on CH Biotech R&D Co and its competitors. CH Biotech R&D Co's current Interest Expense is NT$-17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Fairly Valued. The stock's GF Value™ is NT$100.68, compared to a current price of NT$93.00 — trading 7.6% below its estimated fair value. The current Interest Expense is NT$-17 Mil. CH Biotech R&D Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current Interest Expense is NT$-17 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?

Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued. The current stock price of NT$93.00 is trading 7.6% below its estimated GF Value™ of NT$100.68. GuruFocus considers CH Biotech R&D Co to be Fairly Valued.

Key valuation signals for TPE:6534:

  • Interest Expense: NT$-17 Mil
  • GF Value™: NT$100.68 vs. price of NT$93.00 (7.6% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CH Biotech R&D Co Business Description

Address No. 89, Wenxian Road, Nantou County, Nantou City, TWN, 540001
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score

Get the complete analysis for TPE:6534

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$93.00
Price
NT$100.68
GF Value